WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

The Tracker / July 2026 / K260206

510(k) cleared

SkeletonPlanner

UPlanner B.V. - Presurgeo · Jul 15, 2026 · K260206

FDA cleared the SkeletonPlanner from UPlanner B.V. - Presurgeo on Jul 15, 2026 under K260206, a traditional 510(k). The device falls under product code QIH, Automated Radiological Image Processing Software, regulated at 21 CFR 892.2050 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on Jan 23, 2026. The decision came 173 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for UPlanner B.V. - Presurgeo in the last 12 months of the tracker.

Questions & Answers

What did FDA clear under K260206?

K260206 is the FDA 510(k) for SkeletonPlanner, submitted by UPlanner B.V. - Presurgeo. FDA's decision date was Jul 15, 2026, under product code QIH (Automated Radiological Image Processing Software).

Who makes the SkeletonPlanner?

UPlanner B.V. - Presurgeo, based in Vreeland, is the applicant of record for K260206.

How long did the K260206 review take?

FDA received the submission on Jan 23, 2026 and issued its decision on Jul 15, 2026, 173 days later.

← All decisions in July 2026